A novel vaccine containing protective antigens derived from Piscirickettsia salmonis, Infectious Pancreatic Necrosis Virus (IPNV) and atypical Vibrio ordalii. The vaccine was developed by Microtek Research and Development Ltd.
Product Description
Contains protective antigens produced via recombinant DNA technology (SRS and IPNV) and inactivated bacterin (atypical V. ordalii).
Stable water-in-oil adjuvant system gives minimum side effects and excellent long-term protection.
Uniquely designed recombinant antigens promote high levels of T-cell mediated immunity against P. salmonis and IPNV.
Administered to salmonids by intraperitoneal injection.
Easy to inject at low temperatures.
Recommended Use
Inject pre-smolts prior to saltwater transfer.
Administration
Injection volume 0.1 ml, intraperitoneally.
Recommended needle size, 22 - 25 gauge.
500 ml will vaccinate 5,000 fish.
Minimum fish size, 10 grams.
Considerations
Vaccinate only healthy fish.
Store at 2º - 8 ºC (35º - 45ºF).
Shake well before use.
Connections to the bottle should be made aseptically.
Use entire contents when first opened.
Do not store partially used vaccine bottles.
Vaccination should precede potential exposure to pathogens by at least 450-degree days.*
Do not vaccinate within 21 days of slaughter.
Anaesthetize fish prior to injection vaccination.
Accidental injection in humans may cause a severe allergic response; medical attention should be sought immediately.
*Number of days multiplied by the mean water temperature in degrees of Celsius).